ULBI

Over the past six months, Ultralife Corp. (ULBI) stock was $6.36 as of October 7, 2026, showing a 4.43% rise over the last month, a 1.09% fall compared to the previous week, and a 6.94% decrease over the last year. Following its earnings report on August 7, 2026, the stock gained +19.4% and subsequently drifted +1.9% higher over the next 23 days. Q2 2026 earnings highlighted revenue of $47.9 million, a record backlog nearing $130 million, and strong gross margin gains, led by Communications Systems. Earlier, Q1 2026 saw declines in revenue and gross margin due to shipment delays and one-time costs, despite a record backlog. In Q4 2025, revenue rose 10.6% year-over-year, but a one-time impairment resulted in a net loss, with backlog reaching $110 million. Q3 2025 reported revenue growth to $43.4 million but a net loss of $0.07 per share due to one-time costs and supply chain issues. The stock has also been noted for crossing above its 200-day moving average.